Advances in research on tumor targeted therapy of trastuzumab / 基础医学与临床
Basic & Clinical Medicine
; (12): 722-726, 2018.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-693972
Biblioteca responsável:
WPRO
ABSTRACT
Trastuzumab is a humanized monoclonal antibody that targets at human epidermal growth factor receptor 2(Her2)proto-oncogenes,which can act on Her2 over-expression of tumor cells,inhibits tumor cells proliferation, differentiation,migration and other physiological activities,reduces the risk of tumor metastasis and extend the sur-vival time of patients.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Basic & Clinical Medicine
Ano de publicação:
2018
Tipo de documento:
Artigo